18:2 PA
Manufacturer: Sigma Aldrich
CAS Number: 322647-62-1
Synonym(S): 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate (sodium salt); PA(18:2(9Z,12Z)/18:2(9Z,12Z))
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 840885C-25-MG | In Stock | ₹ 45,887.40 |
840885C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 45,887.40
GST (18%): ₹ 8,259.732
Total Price: ₹ 54,147.132
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 2.5 mL (840885C-25mg)
manufacturer/tradename
Avanti Polar Lipids 840885C
concentration
10 mg/mL (840885C-25mg)
lipid type
phospholipids
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C39H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,37H,3-10,15-16,21-36H2,1-2H3,(H2,42,43,44);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t37-;/m1./s1
InChI key
UMYNPOZOTCNQKB-DKSSBCNHSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 18:2 PA | Sigma Aldrich | ₹ 50,433.68 |
Related Products
Description
- General description: Phosphatidic acid (PA) is a precursor of lysophosphatidic acid (LPA) and is present in leafy vegetables.[1] 18:2 PA or 1,2-dilinoleoyl-sn-glycero-3-phosphate (sodium salt) is a sodium salt of glycerol phosphate, with substitution of two chains of linolenic acid at the sn-1 and sn-2 positions in the glycerol backbone.
- Application: 18:2 PA or 1,2-dilinoleoyl-sn-glycero-3-phosphate (sodium salt):has been used as a supplement in mouse chow to see changes in small intestine gene expression[1]might be used in saposin-derived lipid nanoparticle (SapNP) formation[2]might be used in vacuolar mimic lipid (VML) proteoliposomes used for content-mixing assays[3]
- Packaging: 5 mL Clear Glass Sealed Ampule (840885C-25mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840885C-25mg)
manufacturer/tradename: Avanti Polar Lipids 840885C
concentration: 10 mg/mL (840885C-25mg)
lipid type: phospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C39H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,37H,3-10,15-16,21-36H2,1-2H3,(H2,42,43,44);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t37-;/m1./s1
InChI key: UMYNPOZOTCNQKB-DKSSBCNHSA-M
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 25 mg (840885P-25mg)
manufacturer/tradename: Avanti Polar Lipids 840885P
concentration: __
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C39H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,37H,3-10,15-16,21-36H2,1-2H3,(H2,42,43,44);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-;/t37-;/m1./s1
InChI key: UMYNPOZOTCNQKB-DKSSBCNHSA-M
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (840886C-25mg)pkg of 2 × 4 mL (840886C-200mg)
manufacturer/tradename: Avanti Polar Lipids 840886C
concentration: 10 mg/mL (840886C-25mg)25 mg/mL (840886C-200mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C43H69O8P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(44)49-39-41(40-50-52(46,47)48)51-43(45)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h11-14,17-20,23-26,29-32,41H,3-10,15-16,21-22,27-28,33-40H2,1-2H3,(H2,46,47,48);/q;+1/p-1/b13-11-,14-12-,19-17-,20-18-,25-23-,26-24-,31-29-,32-30-;/t41-;/m1./s1
InChI key: __
